BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen HP, Lamanna WC, Schiestl M. Totality of Evidence and the Role of Clinical Studies in Establishing Biosimilarity. In: Gutka HJ, Yang H, Kakar S, editors. Biosimilars. Cham: Springer International Publishing; 2018. pp. 601-28. [DOI: 10.1007/978-3-319-99680-6_22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 MacDonald K, Alrawashdh N, McBride A, Abraham I. Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancer. Future Oncol 2021. [PMID: 34382416 DOI: 10.2217/fon-2021-0718] [Reference Citation Analysis]